Clinical trial
A Randomized Clinical Trial of Cutaneous Xylocaine Spray to Reduce Intravenous Cannulation Pain in Adults
NCT02562144 is registered in ClinicalTrials.gov with Isala as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Clinical Trial of Cutaneous Xylocaine Spray to Reduce Intravenous Cannulation Pain in Adults
- Lead sponsor
- Isala
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 5, 2016
- Completion date
- April 7, 2016
- Enrollment
- 17 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.